Last reviewed · How we verify

NCT03871010

Midline Programme - Vascular Nursing Team

Completed Last updated 6 October 2020
What this trial tests

trial testing Midline catheter in Inflammation in 100 participants. Completed in 30 April 2020.

Timeline
1 February 2017
Primary endpoint
30 April 2020
30 April 2020

Quick facts

Lead sponsorUniversity Hospital Ostrava
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date1 February 2017
Primary completion30 April 2020
Estimated completion30 April 2020
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Ostrava

Who can join

18 and older, any sex, with Inflammation or Local; Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Integration of the Vascular Nursing Team of the Department of Haematooncology, University Hospital Ostrava for the needs of all clinical departments of the hospital. Assessment of local signs of inflammation in patients of the Department of Haematooncology and other clinical departments of the University Hospital Ostrava.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Midline catheter

Trials testing the same drug.

Other recruiting trials for Inflammation

Currently open trials in the same condition.

Other University Hospital Ostrava trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03871010.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing